Part,  Chapter, Paragraph

  1    I,     2.  4    |      Czech Republic and Slovenia to 21% in Greece, Ireland and
  2    I,     2. 11    |             Health. htt m (accessed 21.11.06).~European Commission (
  3    I,     3.  3    |             the European Union from 21.6 in 1980 to 25.5 in 2005.
  4    I,     3.  4    |           United States? Demography 21(4) pp. 591-611.~ ~Esveldt,
  5    I,     3.  4    |             English Selection, Vol. 21, No. 4: 303-316~ ~
  6   II,     5.  2.  2|       assessed in 37 populations of 21 countries the relative contribution
  7   II,     5.  2.  3|             136 to 82 per 100.000), 21% in Northern countries (
  8   II,     5.  2.  3|         from 99 to 54 per 100.000), 21% in Northern countries (
  9   II,     5.  2.  3|        Mortality rates increased by 21% in Eastern Europe (from
 10   II,     5.  3.  5|     associated with GDP (Figure 5.3.21). This could be caused by
 11   II,     5.  3.  5|    screening programs.~ ~Figure 5.3.21. Cervical cancer (ICD9 180)
 12   II,     5.  4.  1|           people), with an expected 21 % increase to 9.1% (about
 13   II,     5.  4.  3|              with a median value of 21 for France. Important variations
 14   II,     5.  4.  3|       reported an incidence between 21 (Cyprus) and 2135 (Austria),
 15   II,     5.  4.  8|         projections. Diabetes Care, 21(9):1414-31~Massi Benedetti
 16   II,     5.  5.  1|             is based on a sample of 21,425 non-institutionalized
 17   II,     5.  5.  1|        Psychiatr Scand (suppl 420): 21-27.~ ~Alonso J, Angermeyer
 18   II,     5.  5.  3|             study.~J Gen Intern Med 21(11):1133-7.~Coodin S (2001):
 19   II,     5.  5.  3|              Kessler RC). JAMA 291 (21):2581-2590.~World Health
 20   II,     5.  5.  3|            Z J Psychiatry.39(6):514-21.~ ~
 21   II,     5.  5.  3|             etiological factors (14-21%) followed by trauma (2-
 22   II,     5.  5.  3|   employment in epilepsy. Epilepsia 21:235-242.~Beghi E, Cornaggia
 23   II,     5.  5.  3|       Oxford, Blackwell Science; p. 21-42.~Forsgren L, Beghi E,
 24   II,     5.  5.  3|       Maltese.~Prevalence of 39 and 21 per 100 000 has been reported
 25   II,     5.  5.  3|           Survey. Neuroepidemiology 21:226-234.~Becus T, Popoviciu
 26   II,     5.  5.  3|             foods. Mov Disord 14(1):21-27.~Andlin-Sobocki P, Jonsson
 27   II,     5.  5.  3|            Scandinavica 42:Suppl 24:21-89.~Bundesamt für Statistik (
 28   II,     5.  5.  3|  Parkinsonism Relat Disord 10(1):19-21.~Orphanet (2007): Prävalenzen
 29   II,     5.  6.  6|          Health Survey. J Rheumatol 21:505-514~Badley EM, Tennant
 30   II,     5.  6.  6|     functional ability. J Rheumatol 21:1432-1437~Hochberg MC, Chang
 31   II,     5.  6.  6|      Rheumatology(Oxford) 42(4):516-21~Kallman DA, Wigley FM, Scott
 32   II,     5.  6.  6|            Pract Res Clin Rheumatol 21(5):871-83~Office for National
 33   II,     5.  7.  3|            corresponding figure was 21 cases pmarp (Esbjorner et
 34   II,     5.  7.  3|            52% in all patients, and 21%, 32% and 72% for patients
 35   II,     5.  7.  7|            Pediatr Nephrol 2006 Mar;21(3):394-9.~Gansevoort RT,
 36   II,     5.  7.  7|            Dial Transplant 2006 Jul;21(7):1899-905.~Meisinger C,
 37   II,     5.  7.  7|            Dial Transplant 2006 Aug;21(8):2178-83.~Tonelli M, Wiebe
 38   II,     5.  8.  3|           as body mass index (BMI) <21 kg/m2 and/or fat-free mass
 39   II,     5.  9.  2|         with status asthmaticus 493.21Unspecified asthma without
 40   II,     5.  9.  2|             acute) exacerbation 491.21Nasal turbinate hypertrophy
 41   II,     5.  9.  4|            wheeze and 1.02 (0.85, 1.21) for those with wheeze and
 42   II,     5.  9.  4|    prevalent (median between centre 21.7%, 16.9% and 8.8%, respectively).
 43   II,     5.  9.  7|         Allergy. 2006 Apr;61(4):414-21.~ ~Anderson HR, Ruggles
 44   II,     5. 10.  2|          including 56 partners from 21 countries (19 European)
 45   II,     5. 10.  7|             Directive 2005/26/EC of 21 March 2005 establishing
 46   II,     5. 11.  3|            yrs)~Lifetime prevalence=21.3% 1-year prevalence=6.7%
 47   II,     5. 11.  3|            percentages of 20.8% and 21.9 % for nickel allergy,
 48   II,     5. 11.  3|      children, Cutis, 1991;47(1):19-21.~Hasan T, Rantanen T, Alanko
 49   II,     5. 13    |          above the optimum level of 21 kg/m2 is among the five
 50   II,     5. 14.  3|         pockets (> 5 mm) is low (10.21%); this underlines that
 51   II,     6.  3.  1|             1). Of the 49 diseases, 21 have incidence levels that
 52   II,     6.  3.  1|       population with half of these 21 also having rising (or steady)
 53   II,     6.  3.  1|             million, to rotavirus21.7 million and to salmonellosis €
 54   II,     6.  3.  3|        still recorded in Latvia (19.21 per 100 000), Lithuania (
 55   II,     6.  3.  5|          137 cases were reported by 21 countries. Italy reported
 56   II,     6.  3.  6|            2004~In 2005, a total of 21 cases were reported by 18
 57   II,     6.  3.  7|          508 cases were reported by 21 countries. Sweden (2.73
 58   II,     6.  3.  7|          958 cases were reported by 21 countries. Germany and France
 59   II,     6.  3.  7|           by Greece (14%). In 2005, 21 countries reported just
 60   II,     6.  3.  7|       reported across the EU (total 21 cases). In 2005, five cases
 61   II,     7.  3.  2|          vehicle traffic accidents (21%) and falls (19%) are responsible
 62   II,     7.  4.  1|           This means that estimated 21 million children and youths
 63   II,     7.  4.  4|        aerobics (7%). (see Figure 7.21).Swimming and bathing in
 64   II,     7.  4.  4|        Promotion, 2008).~ ~Figure 7.21. Sports practiced at the
 65   II,     8.  2.  2|        Organization. 1995;73(1):115-21.~WHO (2000): Preventing
 66   II,     9.  1.  1|         Gynecol 1993;168(1 Pt 1):16-21.~De Galan-Roosen AE, Kuijpers
 67   II,     9.  1.  1|       Obstet Gynecol 2000;95(2):215-21.~ ~Kahn B, Lumey LH, Zybert
 68   II,     9.  1.  2|          and chromosomal anomalies (21%) (Table 9.1.2.2).~ ~Chromosomal
 69   II,     9.  1.  2|         Perinatal Epidemiology, Vol 21, pp 363-369.~Macintosh MCM,
 70   II,     9.  3.  1|    population, Sweden had less than 21 deaths whereas Latvia had
 71   II,     9.  3.  1|             expected to increase by 21% in the European Region
 72   II,     9.  3.  2|         Gynecol 1993;168(1 Pt 1):16-21.~ ~Cnattingius S (2004):
 73   II,     9.  3.  2|       Obstet Gynecol 2000;95(2):215-21.~ ~Jackson RA, Gibson KA,
 74   II,     9.  3.  3|            life so far, compared to 21% of the general male population.
 75   II,     9.  4.  5|           demographic change Health 21health for all in the
 76   II,     9.  5.  3|                 them~Netherlandse~· 21% of all wome ed between 20
 77   II,     9.  5.  3|              23.1%) and Luxembourg (21.7%) had the highest rates.
 78   II,     9.  5.  6|              Available at: accessed 21.04.08)~ ~National Statistics
 79  III,    10.  2.  1|           victims losing on average 21 years of life expectancy.
 80  III,    10.  2.  1|       Épidémiologique hebdomadaire. 21-22:198-200 [On-line publication
 81  III,    10.  2.  1|             Programme (PEP) (ECE/AC.21/2002/9-EUR/02/5040828/9)-
 82  III,    10.  2.  1|          above the optimum level of 21 kg/m2 is among the five
 83  III,    10.  2.  1|           broad food categories and 21 subcategories. In order
 84  III,    10.  2.  1|            and girls), Spain (boys: 21.3%; girls: 20.2%) and Austria (
 85  III,    10.  2.  1|            was organized by EFSA on 21 and 22 March 2006 (EFSA,
 86  III,    10.  2.  1|           COLLOQUIUM, Parma, Italy, 21-22 March 2006 [http://www.
 87  III,    10.  2.  1|             Directive 2006/34/EC of 21 March 2006 amending the
 88  III,    10.  2.  1|           THE PEP). Geneva, (ECE/AC.21/2002/9-EUR/02/5040828/9): (
 89  III,    10.  2.  1|         unece.org/doc/ece/ac/ece.ac.21.2002.9.e.pdf).~ ~Visscher
 90  III,    10.  2.  5|           human development 2003;75:21-33.~Black J (1998): How
 91  III,    10.  3.  1| electromagnetic fields”, adopted on 21 March 2007.~ ~Noise exposure
 92  III,    10.  3.  1|             UVR. In 2002, more than 21 000 new cases of melanoma
 93  III,    10.  3.  1|            issued a Recommendation (21 February 1990) on the protection
 94  III,    10.  3.  1|            on Human Health. Adopted 21 March 2007 after public
 95  III,    10.  3.  3|            Diseases Control (ECDC), 21 have incidence levels that
 96  III,    10.  3.  3|       population with half of these 21 also having rising (or steady)
 97  III,    10.  3.  4|     Portugal by 47% and in Italy by 21%, amounting to 92% of all
 98  III,    10.  4.  1|           Brussels SEC (2005) 1133, 21 9.2005). Available at: htt ~ ~
 99  III,    10.  4.  2|          set up by Council Decision 21 19/98/EC;~• the control
100  III,    10.  4.  2|         requirements (Article 14 to 21), already existing in many
101  III,    10.  4.  2|         Directive No. 2006/34/EC of 21 March 2006 amending the
102  III,    10.  4.  2|              present and future. 20-21 November 2007.~ ~EFSA/WHO(
103  III,    10.  4.  3|          from 70.0 (per 100 000) to 21.6 in the Commonwealth of
104  III,    10.  4.  5|            with energy recovery and 21% is unspecified. Therefore,
105  III,    10.  4.  5|            with energy recovery and 21 % is unspecified (data from
106  III,    10.  4.  5|           even higher, growing from 21%-35%. In Eastern European
107  III,    10.  5.  1|      Housing and Built Environment, 21(4):397-411.~Muzet A, (2007):
108  III,    10.  5.  2|           in rural areas; Portugal: 21% versus 33%; Greece: 22%
109  III,    10.  5.  2|            29%; but also in France: 21% versus 30%). There is however
110  III,    10.  5.  2|          difference also in Sweden (21% versus 29%) and a rather
111  III,    10.  5.  3|          healthcare (€105 billion), 21% to productivity losses (€
112  III,    10.  6.  2|             to the collaboration of 21 national health promotion
113  III,    10.  6.  2|             to the collaboration of 21 national health promotion
114   IV,    11.  3.  2|          allowable profit is set at 21% rate of return on capital).
115   IV,    11.  5.  6|           January 24, 2002. Article 21 bans any financial aspect
116   IV,    11.  5.  6|           Recommendation No. R (99) 21 of the Committee of Ministers
117   IV,    11.  6.  2|        total expenditure in 1992 to 21% in 1997 (Balabanova, 2002).
118   IV,    11.  6.  3|            2003). In Germany, about 21% of the population can choose
119   IV,    11.  6.  4|           Austria and Germany (with 21 and about 290 insurance
120   IV,    11.  6.  4|      Ministry of Health and Regions~21 regional governments~Age,
121   IV,    11.  6.  4|            Social Insurance Agency; 21 county councils; 290 municipalities~
122   IV,    11.  6.  5|           Assessment in Health Care 21(1): 10-18.~ ~Illich I (1975):
123   IV,    11.  6.  5|          the use of medical care in 21 OECD countries. Paris, OECD.~ ~
124   IV,    12. 10    |            young drivers (under age 21 or during qualifying period)
125   IV,    12. 10    |         life style interventions.~§ 21 SGB V (prevention of dental
126   IV,    12. 10    |            hygiene~Intermediate~ ~§ 21 SGB V prevention of dental
127   IV,    12. 10    |            initiatives like “Agenda 21aim at the implementation
128   IV,    12. 10    |            the government issued on 21 December 2006 a Screening
129   IV,    12. 10    |              and county councils (n=21) have their own tax-levying